1. Home
  2. ALCYU vs LYEL Comparison

ALCYU vs LYEL Comparison

Compare ALCYU & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCYU
  • LYEL
  • Stock Information
  • Founded
  • ALCYU N/A
  • LYEL 2018
  • Country
  • ALCYU
  • LYEL United States
  • Employees
  • ALCYU 3
  • LYEL N/A
  • Industry
  • ALCYU
  • LYEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALCYU
  • LYEL Health Care
  • Exchange
  • ALCYU NYSE
  • LYEL Nasdaq
  • Market Cap
  • ALCYU N/A
  • LYEL 263.9M
  • IPO Year
  • ALCYU N/A
  • LYEL 2021
  • Fundamental
  • Price
  • ALCYU $10.98
  • LYEL $0.65
  • Analyst Decision
  • ALCYU
  • LYEL Sell
  • Analyst Count
  • ALCYU 0
  • LYEL 2
  • Target Price
  • ALCYU N/A
  • LYEL $1.00
  • AVG Volume (30 Days)
  • ALCYU N/A
  • LYEL 1.3M
  • Earning Date
  • ALCYU N/A
  • LYEL 02-26-2025
  • Dividend Yield
  • ALCYU N/A
  • LYEL N/A
  • EPS Growth
  • ALCYU N/A
  • LYEL N/A
  • EPS
  • ALCYU N/A
  • LYEL N/A
  • Revenue
  • ALCYU N/A
  • LYEL $63,000.00
  • Revenue This Year
  • ALCYU N/A
  • LYEL N/A
  • Revenue Next Year
  • ALCYU N/A
  • LYEL N/A
  • P/E Ratio
  • ALCYU N/A
  • LYEL N/A
  • Revenue Growth
  • ALCYU N/A
  • LYEL N/A
  • 52 Week Low
  • ALCYU N/A
  • LYEL $0.58
  • 52 Week High
  • ALCYU N/A
  • LYEL $3.26
  • Technical
  • Relative Strength Index (RSI)
  • ALCYU 46.01
  • LYEL 34.74
  • Support Level
  • ALCYU $11.07
  • LYEL $0.60
  • Resistance Level
  • ALCYU $11.10
  • LYEL $0.71
  • Average True Range (ATR)
  • ALCYU 0.00
  • LYEL 0.06
  • MACD
  • ALCYU 0.00
  • LYEL 0.01
  • Stochastic Oscillator
  • ALCYU 0.00
  • LYEL 23.51

About ALCYU ALCHEMY INVTS ACQUISITION CORP 1 UNIT 1 CL A COM & 1/2 WT

Alchemy Investments Acquisition Corp 1 is a blank check company.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: